Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseases

Gynecologic Oncology

Volumn 70, Issue 2, 1998, Pages 231-235

  Fujiwara, Keiichi ^a   Yamauchi, Hideaki ^a   Yoshida, Takashi ^a   Suzuki, Sachiko ^a   Oda, Takashi ^a   Kohno, I ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOLOGY; FEMALE; HUMAN; IMPLANTABLE PORT SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; OVARY CANCER; PAPANICOLAOU TEST; PERITONEUM; PRIORITY JOURNAL; SECOND LOOK SURGERY; TREATMENT OUTCOME;

EID: 0032142910     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5075     Document Type: Article

References (18)

1. Ozols R F, Rubin S C, Thomas G, Robboy S. Epithelial ovarian cancer. Principles and Practice of Gynecologic Oncology. 1997;Lippincott-Raven, Philadelphia. p. 919-986.
2. Alberts D S, Liu P Y, Hannigan E V, O'Toole R, Williams S D, Young J A, Franklin E W, Clarke-Pearson D L, Malviya V K, DuBeshter B, Adelson M D, Hoskins W J. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med. 335:1996;1950-1955.
3. Barter J F, Barnes W A. Second-look laparotomy. Rubin S C, Sutton G P. Ovarian Cancer. 1993;McGraw-Hill, New York.
4. Lund B, Jacobsen K, Rasch L, Jensen F, Olesen K, Feldt-Rasmussen K. Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinoma. Gynecol Oncol. 37:1990;279-283.
5. Niloff J M, Knapp R C, Lavin P T, Malkasian G D, Berek J S, Nortel R, Whitney C, Zurawski V R, Bast R C. The CA125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol. 155:1986;56-60.
6. Markman M. CA-125: an evolving role in the management of ovarian cancer. J Clin Oncol. 14:1996;1411-1412.
7. Markman M, Reichman B, Hakes T, Curtin J, Barakat R, Rubin S, Jones W, Lewis J L Jr, Almadrones L, Hoskins W. Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy. Cancer Res Clin Oncol. 118:1992;391-394.
8. Rubin S C, Hoskins W J, Hakes T B, Hakes T B, Markman M, Reichman B S, Chapman D, Lewis J L Jr. Serum CA-125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol. 160:1989;667-671.
9. Niloff J M, Bast R J, Schaetzl E M, Knapp R C. Predicitive value of CA-125 antigen levels in second look procedures for ovarian cancer. Am J Obstet Gynecol. 151:1985;981-986.
10. McGowan L, Bunnag B. The evaluation of therapy for ovarian cancer. Gynecol Oncol. 4:1976;375.
11. Rubn S C, Dulaney E D, Markman M, Hoskins W J, Sigo P E, Lewis J L. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol. 71:1988;851-853.
12. Kudo R, Takashina T, Ito E, Mizuuchi H, Sagae S, Moriwaka O, Tamagawa A. Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients. Acta Cytol. 34:1990;545-548.
13. Ravinsky E. Cytology of peritoneal washings in gynecologic patients: diagnostic criteria and pitfalls. Acta Cytol. 30:1986;8-16.
14. Sneige N, Fanning C V. Peritoneal washing cytology in women: diagnostic pitfalls and clues for correct diagnosis. Diagn Cytopathol. 8:1992;632-640.
15. Ziselman E M, Harkaby S E, Hogan J, West W, Atkinson B. Peritoneal washing cytology uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol. 23:1984;105-110.
16. Zuna R E, Michell M L. Cytologic findings in peritoneal washings associated with benign gynecologic disease. Acta Cytol. 32:1988;139-147.
17. Davidson S A, Rubin S C, Markman M, Jones W B, Hakes T B, Reichman B, Almadrones L, Chapman D, Lewis J L Jr, Hoskins W. Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system. Gynecol Oncol. 41:1991;101-106.
18. Markman, M, Hakes, T, Reichman, B, Rubin, S, Curtin, J, Barakat, R, Jones, W, Lewis, J, L, Jr, Almadrones, L, Hoskins, W, Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: Influence of increasing the volume of treatment.